Skip NavigationSkip to Content

Effect of Suppressive Oligodeoxynucleotides on the Development of Inflammation-Induced Papillomas

  1. Author:
    Ikeuchi, H.
    Kinjo, T.
    Klinman, D. M.
  2. Author Address

    [Ikeuchi, H; Kinjo, T; Klinman, DM] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA;Klinman, DM (reprint author), NCI, Canc & Inflammat Program, Bldg 567,Rm 205, Frederick, MD 21702 USA;klinmand@mail.nih.gov
    1. Year: 2011
    2. Date: May
  1. Journal: Cancer Prevention Research
    1. 4
    2. 5
    3. Pages: 752-757
  2. Type of Article: Article
  3. ISSN: 1940-6207
  1. Abstract:

    Inflammation contributes to the development of papillomas and squamous cell carcinomas in the well-established 7,12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-l3-acetate (TPA) model of skin carcinogenesis. Synthetic oligonucleotides (ODN) containing repetitive TTAGGG motifs have been shown to block deleterious inflammatory reactions in murine models of autoimmunity, pneumonitis, and shock. This article examines whether treatment with suppressive (Sup) ODN can interfere with DMBA/TPA-induced inflammation, thereby reducing papilloma formation. Results indicate that Sup ODN block TPA-dependent skin hyperplasia, edema, and leukocytic infiltration. Sup ODN also inhibit the upregulation of genes encoding pro-oncogenic chemokines and other markers of inflammation including CXCL2, CCL2, COX-2, and ODC (omithine decarboxylase). Of greatest import, Sup ODN reduce papilloma formation in a dose- and sequence-dependent manner. These findings suggest that Sup ODN may provide a novel means of preventing inflammation and associated oncogenesis. Cancer Prev Res; 4(5); 752-7. (c) 2011 AACR.

    See More

External Sources

  1. DOI: 10.1158/1940-6207.capr-10-0290
  2. WOS: 000290201100016

Library Notes

  1. Fiscal Year: FY2010-2011
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel